Milestones in Personalized Medicine: From the Ancient Time to Nowadays-the Provocation of COVID-19

被引:26
作者
Visvikis-Siest, Sophie [1 ,2 ]
Theodoridou, Danai [1 ,2 ]
Kontoe, Maria-Spyridoula [1 ,2 ]
Kumar, Satish [1 ,2 ]
Marschler, Michael [1 ,2 ]
机构
[1] Univ Lorraine, IGE PCV, Nancy, France
[2] Santorini Conf SCs Assoc, Nancy, France
关键词
public health; personalized medicine; pharmacogenomics; inflammation; COVID− 19; BREAST-CANCER; HEALTH-CARE; PHARMACOGENETICS; PRIMAQUINE; HYDROXYLATION; DEBRISOQUINE; TRASTUZUMAB; MECHANISMS; BIOMARKERS; BARRIERS;
D O I
10.3389/fgene.2020.569175
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The first evidence of individual targeting medicine appeared in ancient times thousands of years ago. Various therapeutic approaches have been established since then. However, even nowadays, conventional therapies do not take into consideration individuals' idiosyncrasy and genetic make-up, failing thus to be effective in some cases. Over time, the necessity of a more precise and effective treatment resulted in the development of a scientific field currently known as "personalized medicine." The numerous technological breakthroughs in this field have acknowledged personalized medicine as the next generation of diagnosis and treatment. Although personalized medicine has attracted a lot of attention the last years, there are still several obstacles hindering its application in clinical practice. These limitations have come to light recently, due to the COVID-19 pandemic. This review describes the "journey" of personalized medicine over time, emphasizing on important milestones achieved through time. Starting from the treatment of malaria, as a first more personalized therapeutic approach, it highlights the need of new diagnostic tools and therapeutic regimens based on individuals' genetic background. Furthermore, it aims at raising global awareness regarding the current limitations and the necessity of a personalized strategy to overpass healthcare problems and hence, the current crisis.
引用
收藏
页数:12
相关论文
共 64 条
[1]   Perspective: Does personalized medicine hold the future for medicine [J].
Agyeman, Akosua Adom ;
Ofori-Asenso, Richard .
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2015, 7 (03) :239-244
[2]   Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases [J].
Ai, Tao ;
Yang, Zhenlu ;
Hou, Hongyan ;
Zhan, Chenao ;
Chen, Chong ;
Lv, Wenzhi ;
Tao, Qian ;
Sun, Ziyong ;
Xia, Liming .
RADIOLOGY, 2020, 296 (02) :E32-E40
[3]   Biomarkers and Heart Disease [J].
Albert, Michelle A. .
JOURNAL OF CLINICAL SLEEP MEDICINE, 2011, 7 (05) :S9-S11
[4]   COVID-19: too little, too late? [J].
不详 .
LANCET, 2020, 395 (10226) :755-755
[5]  
[Anonymous], 2016, Testing for G6PD Deficiency for Safe Use of Primaquine in Radical Cure of P. vivax and P. ovale
[6]  
[Anonymous], 2007, NIH CURR SUPPL SER
[7]   Primaquine: the risks and the benefits [J].
Ashley, Elizabeth A. ;
Recht, Judith ;
White, Nicholas J. .
MALARIA JOURNAL, 2014, 13
[8]   THE HEMOLYTIC EFFECT OF PRIMAQUINE AND RELATED COMPOUNDS - A REVIEW [J].
BEUTLER, E .
BLOOD, 1959, 14 (02) :103-139
[9]   The distinctive nature of HER2-positive breast cancers [J].
Burstein, HJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (16) :1652-1654
[10]  
Cascella M., 2020, FEATURES EVALUATION